Therapeutic compositions containing macitentan
Abstract:
The invention relates to a product containing the compound of formula (I) below or a pharmaceutically acceptable salt of this compound, in combination with at least one compound having prostacyclin receptor (IP) agonist properties, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0